大腸がん市場レポート：2030年までの動向、予測、競合分析

大腸がんの動向と予測

世界の大腸がん市場は、2024年から2030年までのCAGRが4.1%で、2030年までに219億米ドルに達すると推定されます。この市場の主な促進要因は、高齢者人口の増加、個人の不健康な食習慣と異食タイミングの増加、大腸がんに対する意識の高まりです。世界の大腸がん市場は、手術・放射線療法、化学療法、標的療法、薬物療法への耐性などの市場機会があり、将来性が期待されます。

大腸がん市場の洞察

Lucintelは、触指による直腸検査は正確な診断検査の実施による様々な治療手技への注目の高まりにより、予測期間中に最も高い成長が見込まれると予測しています。

化学療法は一般的に、抗がん剤を静脈に注射するか経口投与する治療法であり、血流にのって直接体内に到達するため、大腸がんの治療に最もよく使われる方法です。

北米は、大腸がんの診断と治療に対する消費者の意識の高まりと、この地域における大腸がんの処置と薬剤の開発に対する政府の支援の増加により、予測期間中に最も高い成長が見込まれています。

本レポートは以下の11の主要な質問に答えている：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の大腸がん市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の大腸がん市場動向（2018～2023年）と予測（2024～2030年）
• 診断別の世界の大腸がん市場
  • 触指による直腸検査
  • 便潜血検査
  • フレキシブルS状結腸鏡検査
  • 結腸内視鏡検査
  • バーチャル結腸内視鏡検査
• 治療別の世界の大腸がん市場
  • 手術・放射線療法
  • 化学療法
  • 標的療法
  • 薬物療法に対する耐性
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の大腸がん市場
• 北米の大腸がん市場
• 欧州の大腸がん市場
• アジア太平洋の大腸がん市場
• その他地域の大腸がん市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 診断別の世界の大腸がん市場の成長機会
  • 治療別の世界の大腸がん市場の成長機会
  • 地域別の世界の大腸がん市場の成長機会
• 世界の大腸がん市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の大腸がん市場の能力拡大
  • 世界の大腸がん市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abbott Diagnostics
• Alere
• Beckman Coulter
• Clinical Genomics
• Companion Dx
• Hoffmann La Roche
• Debiopharm
• Vaccinogen BD

Colorectal Cancer Trends and Forecast

The future of the global colorectal cancer market looks promising with opportunities in the urgery & radiation therapy, chemotherapy, targeted therapies, and resistance to pharmacological therapies markets. The global colorectal cancer market is expected to reach an estimated $21.9 billion by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are growing geriatric population, increasing unhealthy food habits and odd food consumption timing of individual, and rising awareness towards colorectal cancer.

A more than 150-page report is developed to help in your business decisions.

Colorectal Cancer by Segment

The study includes a forecast for the global colorectal cancer by diagnosis, treatment, and region.

Colorectal Cancer Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

• Digital Rectal Examination
• Fecal Occult Blood Test
• Flexible Sigmoidoscopy
• Colonoscopy
• Virtual Colonoscopy

Colorectal Cancer Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Surgery and Radiation Therapy
• Chemotherapy
• Targeted Therapies
• Resistance to Pharmacological Therapies
• Others

Colorectal Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Colorectal Cancer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer companies profiled in this report include-

• Abbott Diagnostics
• Alere
• Beckman Coulter
• Clinical Genomics
• Companion Dx
• Hoffmann La Roche
• Debiopharm
• Vaccinogen BD

Colorectal Cancer Market Insights

Lucintel forecasts that digital rectal examination is expected to witness highest growth over the forecast period due to growing prominence for the various treatment procedures by performing accurate diagnostic tests.

Within this market, chemotherapy will remain the largest segment as it is generally a treatment with injectable cancer drugs into a vein or orally by mouth, which helps them directly reach body parts through the bloodstream travel and is the most commonly used method to treat colorectal cancer.

North America is expected to witness highest growth over the forecast period due to the increasing awareness among consumers about the diagnosis and treatment of colorectal cancer and growing government support to develop colorectal cancer procedures and drugs in this region.

Features of the Global Colorectal Cancer Market

Market Size Estimates: Colorectal cancer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Colorectal cancer market size by diagnosis, treatment, and region. in terms of value ($B).

Regional Analysis: Colorectal cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatment, and region.s for the colorectal cancer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the colorectal cancer market size?

Answer: The global colorectal cancer market is expected to reach an estimated $21.9 billion by 2030.

Q.2. What is the growth forecast for colorectal cancer market?

Answer: The global colorectal cancer market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the colorectal cancer market?

Answer: The major drivers for this market are growing geriatric population, increasing unhealthy food habits and odd food consumption timing of individual, and rising awareness towards colorectal cancer.

Q.4. What are the major segments for colorectal cancer market?

Answer: The future of the colorectal cancer market looks promising with opportunities in the urgery & radiation therapy, chemotherapy, targeted therapies, and resistance to pharmacological therapies markets.

Q.5. Who are the key colorectal cancer market companies?

Answer: Some of the key colorectal cancer companies are as follows:

• Abbott Diagnostics
• Alere
• Beckman Coulter
• Clinical Genomics
• Companion Dx
• Hoffmann La Roche
• Debiopharm
• Vaccinogen BD

Q.6. Which colorectal cancer market segment will be the largest in future?

Answer: Lucintel forecasts that digital rectal examination is expected to witness highest growth over the forecast period due to growing prominence for the various treatment procedures by performing accurate diagnostic tests.

Q.7. In colorectal cancer market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the increasing awareness among consumers about the diagnosis and treatment of colorectal cancer and growing government support to develop colorectal cancer procedures and drugs in this region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer market by diagnosis (digital rectal examination, fecal occult blood test, flexible sigmoidoscopy, colonoscopy, and virtual colonoscopy), treatment (surgery & radiation therapy, chemotherapy, targeted therapies, resistance to pharmacological therapies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Colorectal Cancer Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Colorectal Cancer Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Colorectal Cancer Market by Diagnosis
  • 3.3.1: Digital Rectal Examination
  • 3.3.2: Fecal Occult Blood Test
  • 3.3.3: Flexible Sigmoidoscopy
  • 3.3.4: Colonoscopy
  • 3.3.5: Virtual Colonoscopy
• 3.4: Global Colorectal Cancer Market by Treatment
  • 3.4.1: Surgery and Radiation Therapy
  • 3.4.2: Chemotherapy
  • 3.4.3: Targeted Therapies
  • 3.4.4: Resistance to Pharmacological Therapies
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Colorectal Cancer Market by Region
• 4.2: North American Colorectal Cancer Market
  • 4.2.2: North American Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
• 4.3: European Colorectal Cancer Market
  • 4.3.1: European Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
  • 4.3.2: European Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
• 4.4: APAC Colorectal Cancer Market
  • 4.4.1: APAC Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
  • 4.4.2: APAC Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
• 4.5: ROW Colorectal Cancer Market
  • 4.5.1: ROW Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
  • 4.5.2: ROW Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Colorectal Cancer Market by Diagnosis
  • 6.1.2: Growth Opportunities for the Global Colorectal Cancer Market by Treatment
  • 6.1.3: Growth Opportunities for the Global Colorectal Cancer Market by Region
• 6.2: Emerging Trends in the Global Colorectal Cancer Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Colorectal Cancer Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colorectal Cancer Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Diagnostics
• 7.2: Alere
• 7.3: Beckman Coulter
• 7.4: Clinical Genomics
• 7.5: Companion Dx
• 7.6: Hoffmann La Roche
• 7.7: Debiopharm
• 7.8: Vaccinogen BD